Assessing Psoriasis Treatment Outcomes
ConditionPsoriasis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWake Forest University Health Sciences
About this trial
To assess the feasibility of AIGPP video interactions with psoriasis patients. To explore patient attitudes, trust, and comfort levels concerning AIGPP interactions in a healthcare setting, and to understand their influence on the patient-physician dynamic. To evaluate medication adherence over a 4-week period in patients with psoriasis randomized to weekly AI-generated automated physician providers (AIGPP) video interactions, weekly human video calls, or standard care (single follow up visit after 4 weeks). Adherence rates will be evaluated via a cap designed to record adherence attached to the study medication container.
Eligibility criteria
Qualifiers
Patients ≥18 years of age
Patients with a current diagnosis of psoriasis suitable for treatment with topical Betamethasone (BD)
Patients who live in the United States
Patients with a sufficient command of the English language
Disqualifiers
Patients less than the age of 18
Patients with severe or unstable comorbid conditions
Patient who are pregnant or breastfeeding
Patients with any other skin conditions that prohibit or confound the ability of the investigator to interpret skin findings
Trial design
Treatments tested in this trial
- Artificial intelligence
- Human
- Standard of Care
Treatment groups
15 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov